跳至主要内容
临床试验/ACTRN12621000240842
ACTRN12621000240842已完成2 期

Comparing Oral and Sublingual Ketamine Lozenges as Rescue Analgesics in Adults with Acute pain

niversity of Western Australia0 个研究点目标入组 30 人开始时间: 2021年3月8日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

Ketamine given sublingually and orally produced similar analgesic effects. Sublingual ketamine has faster onset of action and possibly higher rate of adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1) 18years old or above
  • 2) Inpatients with acute breakthrough pain of 5 or more on numerical rating scale who required additional medication and previously responded to sublingual ketamine.
  • 3) able to self-assess pain scores on NRS

排除标准

  • Patients with known contraindications to ketamine such as: allergy to ketamine; severe cardiovascular disease; history of stroke or cerebral trauma; significant liver disease.
  • Pregnant women or breastfeeding mothers.

研究者

发起方
niversity of Western Australia

相似试验